Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other literature type . 2024
License: CC BY
Data sources: ZENODO
ZENODO
Project deliverable . 2024
License: CC BY
Data sources: Datacite
ZENODO
Project deliverable . 2024
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

D16.5 Guidelines for data sharing of investigator-initiated clinical studies

Authors: Malik, Salma; contrino, sergio; del Alamo, Marta; Lémeret, Sabrina; Demotes-Mainard, Jacques; Kubiak, Christine; Matei, Mihaela; +1 Authors

D16.5 Guidelines for data sharing of investigator-initiated clinical studies

Abstract

The objective of this task is to provide general guidance for preparing data sharing plan for clinical studies, including guidance on informed consent (ICF) for secondary use of data and long-term storage of data, especially Individual Patient Data (IPD) in repositories following the FAIR (Findable, Accessible, Interoperable and Reusable) principles. This guide outlines the process of developing a data sharing plan GDPR compliant and in alignment with the EU and international funders expectations and provides practical guidance on how to meet them. It should be of relevance to stakeholders (funders, grant applicants, coordinating-investigators, research staff, patients’ groups, researchers, academia, professional groups, industry, reviewers, and regulatory and ethics authorities) involved in investigator initiated multinational clinical trials.

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green